<--- Back to Details
First PageDocument Content
Biodefense / Biology / Health / Government / United States Department of Health and Human Services / Biomedical Advanced Research and Development Authority / Office of the Assistant Secretary for Preparedness and Response
Date: 2011-05-09 12:06:52
Biodefense
Biology
Health
Government
United States Department of Health and Human Services
Biomedical Advanced Research and Development Authority
Office of the Assistant Secretary for Preparedness and Response

Public Meeting Thursday, April 28, 2011 Washington Plaza Hotel 10 Thomas Circle Northwest Washington, DC[removed]:15 a.m. – 10:45 a.m.

Add to Reading List

Source URL: www.phe.gov

Download Document from Source Website

File Size: 26,98 KB

Share Document on Facebook

Similar Documents

Assistant Secretary for Preparedness and Response  Fiscal Year 2014 Year In Review What We Do •

Assistant Secretary for Preparedness and Response Fiscal Year 2014 Year In Review What We Do •

DocID: 1q0XI - View Document

U.S. Department of Health and Human Services Assistant Secretary for Preparedness and Response FY 2016 Budget in BrieF An overview of ASPR’s budget request and strategic priorities

U.S. Department of Health and Human Services Assistant Secretary for Preparedness and Response FY 2016 Budget in BrieF An overview of ASPR’s budget request and strategic priorities

DocID: 1pQs3 - View Document

Colorful medical capsules in bottle, on white background.

Colorful medical capsules in bottle, on white background.

DocID: 1lKw6 - View Document

Chapter 8 CBRN Defense: Responding to Growing Threats I

Chapter 8 CBRN Defense: Responding to Growing Threats I

DocID: 1aaRz - View Document

Avaxia Biologics, Inc. Awarded Barda Contract for Therapeutic Countermeasure To Help the Nation Respond To a Radiological Emergency WAYLAND, Mass. – August 3, 2011 – Avaxia Biologics, Inc., a privately-held biotech c

Avaxia Biologics, Inc. Awarded Barda Contract for Therapeutic Countermeasure To Help the Nation Respond To a Radiological Emergency WAYLAND, Mass. – August 3, 2011 – Avaxia Biologics, Inc., a privately-held biotech c

DocID: 19M4s - View Document